KYMAB - Trademark Details
Status: 700 - Registered
Serial Number
88441516
Registration Number
6473731
Word Mark
KYMAB
Status
700 - Registered
Status Date
2021-09-07
Filing Date
2019-05-22
Registration Number
6473731
Registration Date
2021-09-07
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2021-03-23
Attorney Name
Law Office Assigned Location Code
N30
Employee Name
MANGUBAT, ALEXANDER GE
Statements
Goods and Services
Pharmaceutical and medical preparations containing monoclonal antibodies for the treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; Veterinary preparations containing monoclonal antibodies for treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, autoimmune and infectious diseases, and medical diagnostics; sanitary preparations containing monoclonal antibodies for medical purposes; dietetic food and beverages containing monoclonal antibodies, for medical and veterinary use; dietary supplements containing monoclonal antibodies for human beings and animals; dietary supplements containing monoclonal antibodies; Pharmaceutical preparations containing monoclonal antibodies for the treatment of treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases and in the field of antibodies and immuno-oncology
Goods and Services
Scientific, medical and technological services, namely, scientific research, analysis and testing in the field of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology, and scientific research, analysis and testing in the field of antibodies and cell repertoires and research, development and design in the field of science, medicine, and technology; industrial analysis and industrial research services, namely, testing, analysis, and evaluation of the goods of others to assure compliance with industry standards; design and development of computer hardware and software; design and development of hardware and software for analysis and testing in the field of antibodies and biological cells and genetic discovery and clinical development; Clinical research in the field of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies, immuno-oncology, inflammation, haematology and infectious disease; Conducting clinical trials for others in the field of antibodies, and medical conditions, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; conducting clinical trials for pharmaceutical products for others in the field of medical conditions, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; scientific and medical screening and assaying of medical conditions, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; scientific and medical screening and assaying in the field of genetic discovery, clinical development, antibodies and biological cells; chemical analysis; chemical research
Goods and Services
Medical services; diagnostic and prognostic medical services; veterinary services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; pharmaceutical consultation in the nature of pharmacy advice; medical and health services in the nature of the treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics; Medical screening
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-06-06
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-06-06
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-06-06
Primary Code
044
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Mark H. Tidman
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
2019-02-07 | UK0000337361 | United Kingdom | True |
United Kingdom | False | ||
UK0000337361 | True | ||
UK0000337361 | United Kingdom | True |
Trademark Events
Event Date | Event Description |
2019-05-25 | NEW APPLICATION ENTERED IN TRAM |
2019-06-06 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-08-09 | ASSIGNED TO EXAMINER |
2019-08-09 | NON-FINAL ACTION WRITTEN |
2019-08-09 | NON-FINAL ACTION E-MAILED |
2019-08-09 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-01-28 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-01-28 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-01-29 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-02-14 | EXAMINERS AMENDMENT -WRITTEN |
2020-02-14 | EXAMINERS AMENDMENT E-MAILED |
2020-02-14 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2020-02-14 | EXAMINER'S AMENDMENT ENTERED |
2020-02-14 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-02-21 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
2020-02-21 | ELECTRONIC RECORD REVIEW COMPLETE |
2020-03-09 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
2020-03-16 | NON-FINAL ACTION WRITTEN |
2020-03-16 | NON-FINAL ACTION E-MAILED |
2020-03-16 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-08-21 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-08-21 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-08-22 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-10-09 | NON-FINAL ACTION WRITTEN |
2020-10-09 | NON-FINAL ACTION E-MAILED |
2020-10-09 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2021-02-17 | EXAMINERS AMENDMENT -WRITTEN |
2021-02-17 | EXAMINERS AMENDMENT E-MAILED |
2021-02-17 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2021-02-17 | EXAMINER'S AMENDMENT ENTERED |
2021-02-17 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2021-03-03 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2021-03-23 | PUBLISHED FOR OPPOSITION |
2021-03-23 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2021-04-21 | EXTENSION OF TIME TO OPPOSE RECEIVED |
2021-08-01 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
2021-09-07 | REGISTERED-PRINCIPAL REGISTER |